Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
Call us @: 844 663-3742
Study Details
Medical Condition
Study Phase
Intervention Type
Date
Participation Requirements
Gender
Age
Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Have a question?
You can ask us questions via online form or phone call.
Call us @: 844 663-3742
| Location | Status | Site Contact Details |
|---|---|---|
Location Glostrup | Status Not Available | |
Location Oslo | Status Not Available | |
Location Uppsala | Status Not Available |
This multicenter observational study will assess the efficacy and tolerability of OZURDEX® in clinical practice, and will assess the time at which patients are considered for retreatment.
Time to First Re-treatment
Time Frame: 1 Year
Change From Baseline in Best Corrected Visual Acuity (BCVA) Score
Time Frame: Baseline, Weeks 12, 24 and 48
Change From Baseline in Central Retinal Thickness as Measured by Optical Coherence Tomography (OCT)
Time Frame: Baseline, Weeks 12, 24 and 48
Interventions:
- Other: No Intervention
Enrollment:
100
Additional Information
Watch a video to learn more about what you may experience as a clinical trial volunteer: /resources/what-happens-in-a-clinical-trial
Take a virtual reality screening visit tour to an example of a clinical trial site: /resources/screening-visit-virtual-tour
Use a questionnaire tool to think through questions to ask yourself about participating in a clinical trial and print out your responses to discuss with your partners in your health journey: /resource-information-clinical-trial-community/decision-counselor